Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery
Chemotherapy has markedly improved cancer outcomes, yet cancer therapy-related cardiac dysfunction (CTRCD) poses a significant challenge, affecting around 10% of patients. CTRCD can be asymptomatic or present with heart failure symptoms. Multimodality imaging, particularly echocardiography, remains...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2024-08-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849330054398476288 |
|---|---|
| author | Pavel Martinez-Dominguez Maria Jose Santa Ana-Bayona Enrique C. Guerra Nilda Espinola-Zavaleta |
| author_facet | Pavel Martinez-Dominguez Maria Jose Santa Ana-Bayona Enrique C. Guerra Nilda Espinola-Zavaleta |
| author_sort | Pavel Martinez-Dominguez |
| collection | DOAJ |
| description | Chemotherapy has markedly improved cancer outcomes, yet cancer therapy-related cardiac dysfunction (CTRCD) poses a significant challenge, affecting around 10% of patients. CTRCD can be asymptomatic or present with heart failure symptoms. Multimodality imaging, particularly echocardiography, remains pivotal for monitoring cardiac function. Potential biomarkers for CTRCD assessment include troponin and B-type natriuretic peptide. Pharmacological interventions, such as dexrazoxane, angiotensin-converting enzyme inhibitors, and statins, play a crucial role in primary prevention and mitigating cardiotoxicity alongside cardiac rehabilitation programs. Thus, a comprehensive approach is essential for optimal cardiac recovery and improved patient outcomes. |
| format | Article |
| id | doaj-art-2c660cc4843b4806b32a1c4b32fd9a70 |
| institution | Kabale University |
| issn | 1947-6108 |
| language | English |
| publishDate | 2024-08-01 |
| publisher | Houston Methodist DeBakey Heart & Vascular Center |
| record_format | Article |
| series | Methodist DeBakey Cardiovascular Journal |
| spelling | doaj-art-2c660cc4843b4806b32a1c4b32fd9a702025-08-20T03:47:06ZengHouston Methodist DeBakey Heart & Vascular CenterMethodist DeBakey Cardiovascular Journal1947-61082024-08-0120410911210.14797/mdcvj.14301408Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac RecoveryPavel Martinez-Dominguez0https://orcid.org/0009-0008-2821-9692Maria Jose Santa Ana-Bayona1https://orcid.org/0009-0008-3476-9711Enrique C. Guerra2https://orcid.org/0000-0003-0677-9935Nilda Espinola-Zavaleta3https://orcid.org/0000-0002-4820-1325National Institute of Cardiology Ignacio Chavez, Mexico City; Autonomous University of Chihuahua, ChihuahuaNational Institute of Cardiology Ignacio Chavez, Mexico CityNational Institute of Cardiology Ignacio Chavez, Mexico City; National Autonomous University of Mexico, Mexico CityNational Institute of Cardiology Ignacio Chavez, Mexico City; ABC Medical Center, Mexico CityChemotherapy has markedly improved cancer outcomes, yet cancer therapy-related cardiac dysfunction (CTRCD) poses a significant challenge, affecting around 10% of patients. CTRCD can be asymptomatic or present with heart failure symptoms. Multimodality imaging, particularly echocardiography, remains pivotal for monitoring cardiac function. Potential biomarkers for CTRCD assessment include troponin and B-type natriuretic peptide. Pharmacological interventions, such as dexrazoxane, angiotensin-converting enzyme inhibitors, and statins, play a crucial role in primary prevention and mitigating cardiotoxicity alongside cardiac rehabilitation programs. Thus, a comprehensive approach is essential for optimal cardiac recovery and improved patient outcomes.https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1430cardiotoxicitycardiac dysfunctioncardiac recoverycardio-oncology |
| spellingShingle | Pavel Martinez-Dominguez Maria Jose Santa Ana-Bayona Enrique C. Guerra Nilda Espinola-Zavaleta Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery Methodist DeBakey Cardiovascular Journal cardiotoxicity cardiac dysfunction cardiac recovery cardio-oncology |
| title | Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery |
| title_full | Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery |
| title_fullStr | Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery |
| title_full_unstemmed | Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery |
| title_short | Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery |
| title_sort | cancer therapy related cardiac dysfunction strategies for enhancing cardiac recovery |
| topic | cardiotoxicity cardiac dysfunction cardiac recovery cardio-oncology |
| url | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1430 |
| work_keys_str_mv | AT pavelmartinezdominguez cancertherapyrelatedcardiacdysfunctionstrategiesforenhancingcardiacrecovery AT mariajosesantaanabayona cancertherapyrelatedcardiacdysfunctionstrategiesforenhancingcardiacrecovery AT enriquecguerra cancertherapyrelatedcardiacdysfunctionstrategiesforenhancingcardiacrecovery AT nildaespinolazavaleta cancertherapyrelatedcardiacdysfunctionstrategiesforenhancingcardiacrecovery |